Literature DB >> 9343751

Staphylococcal culture supernates stimulate human phagocytes.

K E Veldkamp1, K P Van Kessel, J Verhoef, J A Van Strijp.   

Abstract

Phagocytes play a major role in host defense against staphylococci as well as in the pathophysiology of Gram-positive septic shock. In Gram negative sepsis, the main mediator, LPS exerts its effects as easily suspendable mediator. In Gram positive sepsis the main mediator is still not found, therefore we studied the interaction of soluble staphylococcal products with phagocytes. Staphylococcus aureus supernates (SaS) were harvested from several laboratory and clinical strains that were grown to late-log phase. These supernates upregulated CD11b/CD18 expression on human neutrophils even in a 100-fold dilution. SaS also induced the release of TNF-alpha and IL-1 beta by human monocytes. Control experiments excluded peptidoglycan, lipoteichoic acid, alpha and delta toxin, leucocidin, TSST-1 and all enterotoxins as sole mediators. Endotoxin contamination was also excluded. SaS was heat-stable; incubation for 45 minutes at 100 degrees C did not affect its activity. Compared to purified peptidoglycan and intact bacteria per bacterium, SaS had a higher potency in stimulating phagocytes. We hypothesize that there are more--yet unknown--soluble staphylococcal products which are very important in phagocyte stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343751     DOI: 10.1023/a:1027315814817

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  In-vitro stimulation of TNF-alpha from human whole blood by cell-free supernatants of gram-positive bacteria.

Authors:  K Bayston; M Tomlinson; J Cohen
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

2.  Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism.

Authors:  S Kasimir; W Schönfeld; J E Alouf; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes.

Authors:  B König; G Prévost; Y Piémont; W König
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

4.  Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein.

Authors:  S Bhakdi; J Tranum-Jensen; G Utermann; R Füssle
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

5.  Chemotaxigenesis by cell surface components of Staphylococcus aureus.

Authors:  D J Schmeling; P K Peterson; D E Hammerschmidt; Y Kim; J Verhoef; B J Wilkinson; P G Quie
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes.

Authors:  S Bhakdi; M Muhly; S Korom; F Hugo
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 7.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.

Authors:  G Prevost; P Couppie; P Prevost; S Gayet; P Petiau; B Cribier; H Monteil; Y Piemont
Journal:  J Med Microbiol       Date:  1995-04       Impact factor: 2.472

9.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.

Authors:  B Weidemann; H Brade; E T Rietschel; R Dziarski; V Bazil; S Kusumoto; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more
  8 in total

1.  Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.

Authors:  C J de Haas; E M van Leeuwen; T van Bommel; J Verhoef; K P van Kessel; J A van Strijp
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.

Authors:  K E Veldkamp; H C Heezius; J Verhoef; J A van Strijp; K P van Kessel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections.

Authors:  Rachel M McLoughlin; Robert M Solinga; Jeremy Rich; Kathleen J Zaleski; Jordan L Cocchiaro; Allison Risley; Arthur O Tzianabos; Jean C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

4.  Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung.

Authors:  Francis J Martin; Dane Parker; Bryan S Harfenist; Grace Soong; Alice Prince
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

Review 5.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Beta-lactam antibiotic-induced release of lipoteichoic acid from Staphylococcus aureus leads to activation of neutrophil granulocytes.

Authors:  Sonja Lotz; Andrea Starke; Christian Ziemann; Siegfried Morath; Thomas Hartung; Werner Solbach; Tamás Laskay
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-06-27       Impact factor: 3.944

7.  An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization.

Authors:  C Mehlin; C M Headley; S J Klebanoff
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

8.  Staphylococcal complement evasion by various convertase-blocking molecules.

Authors:  Ilse Jongerius; Jörg Köhl; Manoj K Pandey; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.